Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of March 31, 2021, it operated a network of 228 behavioral healthcare facilities with approximately 10,000 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
IPO Year:
Exchange: NASDAQ
Website: acadiahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/14/2025 | $26.00 | Strong Buy → Outperform | Raymond James |
| 2/28/2025 | $43.00 → $35.00 | Overweight → Equal Weight | Barclays |
| 1/7/2025 | $70.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/12/2024 | $45.00 → $75.00 | Hold → Buy | Deutsche Bank |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 4/25/2024 | $70.00 | Sell → Hold | Deutsche Bank |
| 3/6/2024 | $100.00 | Overweight | Barclays |
| 4/21/2023 | $83.00 | Neutral | Cantor Fitzgerald |
| 4/20/2023 | $75.00 → $63.00 | Hold → Sell | Deutsche Bank |
| 12/12/2022 | $90.00 → $95.00 | Hold → Buy | Loop Capital |
SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
S-8 - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
DEF 14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
Fastest customizable press release news feed in the world
Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities
Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:20 p.m. Central Time / 11:20 a.m. Pacific Time on Wednesday, May 14th, 2025. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provider of behavi
Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) (the "Company" or "Acadia") announced today the pricing of its private offering (the "Offering") of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the "Notes"), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customary closing and market conditions. The Company intends to use the proceeds from the Offering to prepay the outstanding borrowings under its existing senior secured revolving line of credit. The Notes will bear interest at the rate of
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) (the "Company" or "Acadia") announced today that it has launched a private offering (the "Offering") of $500 million in aggregate principal amount of senior notes due 2033 (the "Notes"), subject to market conditions and other considerations. The Company intends to use the proceeds from the Offering to prepay a portion of the outstanding borrowings under its existing senior secured revolving line of credit. The Notes have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), any state securities laws or the securities laws of any other jurisdiction, and may not be offered or sold in the United States, or for t
Company Provides Full Year and First Quarter 2025 Guidance, Announces $300 Million Share Repurchase Authorization Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjusted income attributab
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in three investor conferences in March. On Tuesday, March 4, 2025, the Company will participate in the Raymond James 46th Annual Institutional Investors Conference, being held March 2-5, 2025, in Orlando, Florida. The Company's presentation will begin at 8:05 a.m. Eastern Time/7:05 a.m. Central Time. On Tuesday, March 11, 2025, the Company will participate in the Leerink Partners 2025 Global Healthcare Conference, being held March 10-12, 2025, in Miami, Florida. The Company's presentation will begin at 2:20 p.m. Eastern Time/1:20 p.m. Central Time. On Wednesday, March 12, 2025, the Company wil
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2024, Acadia operated a network of 260 behavioral
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Raymond James downgraded Acadia Healthcare from Strong Buy to Outperform and set a new price target of $26.00
Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously
KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00
Deutsche Bank upgraded Acadia Healthcare from Hold to Buy and set a new price target of $75.00 from $45.00 previously
KeyBanc Capital Markets initiated coverage of Acadia Healthcare with a rating of Sector Weight
Deutsche Bank upgraded Acadia Healthcare from Sell to Hold and set a new price target of $70.00
Barclays initiated coverage of Acadia Healthcare with a rating of Overweight and set a new price target of $100.00
Cantor Fitzgerald initiated coverage of Acadia Healthcare with a rating of Neutral and set a new price target of $83.00
Deutsche Bank downgraded Acadia Healthcare from Hold to Sell and set a new price target of $63.00 from $75.00 previously
Loop Capital upgraded Acadia Healthcare from Hold to Buy and set a new price target of $95.00 from $90.00 previously
Live Leadership Updates
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i
Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For
Dixon Brings Over 25 Years of Financial and Healthcare Experience David Duckworth to Step Down After 12 Years as Acadia's CFO Larry Harrod, EVP, Finance Announces Retirement; Tim Sides to Assume Responsibilities Company Reaffirms Full Year Fiscal 2023 Guidance Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") today announced Heather Dixon has been appointed Chief Financial Officer (CFO), effective July 10, 2023. Dixon succeeds David Duckworth, who has decided to step down after more than a decade as the Company's CFO. Duckworth will work closely with Dixon in an advisory capacity to support a smooth transition of responsibilities. This press release features
Dr. Khan brings 20 years of healthcare and provider-based experience to this role Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr. Khan will oversee Acadia's network of 145 CTC facilities and associated services. He joined Acadia on September 6th following the retirement of the CTC business' previous group president. Dr. Khan will report to John Hollinsworth, EVP Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914005293/en/Acadia Healthcare Company appointed Dr. Nasser Khan
The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO. It is anticipated that Ms. Osteen's retirement will be effective on January 31, 2022. Reeve Waud, Chairman of Acadia's Board of Directors, said, "Debbie has done an outstanding job as Acadia's CEO with the support of a strong senior team, and the Board could not be more pleased with the Company's progress under Debbie's leadership. We are very appreciative of her efforts in leading the Company through a period of significant progress and
Live finance-specific insights
Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities
Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia
Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri
Company Provides Full Year and First Quarter 2025 Guidance, Announces $300 Million Share Repurchase Authorization Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjusted income attributab
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2024, Acadia operated a network of 260 behavioral
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Highlights Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023 Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue per patient day of 3.6% and an increase in patient days of 4.7% Net income attributable to Acadia totaled $68.1 million, or $0.74 per diluted share Adjusted income attributable to Acadia totaled $84.1 million, or $0.91 per diluted share Adjusted EBITDA totaled $194.3 million, an increase
Clinics are the Company's first opioid use disorder treatment centers in the Palmetto State Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the acquisition of three opioid treatment program clinics in South Carolina, which provide treatment for people seeking recovery from opioid use disorder. The clinics – formerly the opioid treatment programs of Recovery Concepts, Recovery Concepts of the Carolina Upstate, and Clear Skye Treatment Center – will be rebranded within Acadia's Comprehensive Treatment Center (CTC) service line as Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center. These facilities are th
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its third quarter 2024 results on Wednesday, October 30, 2024, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, October 31, 2024. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2024, Acadia operated a network of 258 behavioral healthcare facilitie
Provides Updated Guidance for 2024 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Highlights Revenue totaled $796.0 million, an increase of 8.8% over the second quarter of 2023 Same facility revenue increased 8.3% compared with the second quarter of 2023, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.6% Net income attributable to Acadia totaled $78.5 million, or $0.85 per diluted share Adjusted income attributable to Acadia totaled $83.6 million, or $0.91 per diluted share Adjusted EBITDA totaled $187.6 million, an incr
This live feed shows all institutional transactions in real time.
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)